D-Wave Quantum: A Korean Optimization Pact, Two Lawsuits and the Earnings Test Ahead
Published on 10/29/2026 at 07:20 | Editorial boerse-global.de
D-Wave Quantum closed Wednesday's session down 4.3%, caught in a sector-wide retreat in quantum computing stocks. Media reports pointed to profit-taking after the previous rebound and caution ahead of the Federal Reserve's rate decision as the forces weighing on the group. That headline number, however, sits alongside two separate corporate threads: a fresh non-binding partnership with South Korea's LG CNS and a securities class action that puts the company's own commercial statements under scrutiny.
A memorandum, not an order book
The letter of intent signed Thursday aims to move quantum optimization out of pilot projects and into industrial deployment. D-Wave's annealing technology would be paired with LG CNS's optimization and systems-integration expertise, with applications targeted at manufacturing, telecommunications, finance and retail. The plan covers South Korea and international markets, and includes joint sales opportunities.
LG CNS brings roughly 50 optimization specialists holding master's or doctoral degrees, along with experience from more than 200 optimization projects — a partner with demonstrated implementation capability rather than a purely academic collaborator. The proposed path from proof of feasibility to productive use addresses the question that ultimately determines the economic value of such an alliance: does technical experimentation become an application customers pay for on a sustained basis?
No hardware purchases, licensing fees or commitments to use cloud computing capacity have been disclosed. Nor has an order volume or immediate revenue been named. That omission carries more weight than the breadth of the announced use cases — a long list of applications is no substitute for a paying customer.
The litigation picture
Two law firms have now flagged investor action. Portnoy Law announced Thursday that a securities class action had been filed on behalf of buyers of D-Wave shares between February 26 and August 25, 2026. The complaint alleges misleading statements about order intake, commercial usage and delayed system deliveries. Rosen Law Firm, meanwhile, reminded investors Thursday of the December 15 deadline to seek appointment as lead plaintiff. All of these are allegations, not established facts, and no plaintiff class has yet been certified.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
According to the complaint, order intake declined in 2025. The bookings described as record for 2026 allegedly rested predominantly on two contracts concluded before the relevant purchase period, and therefore demonstrated no new or expanded commercial usage. The suit further claims D-Wave may not have been on track to convert its system sales pipeline into new orders, and that system deliveries and associated revenue could slip into the fourth quarter of 2026 and beyond into 2027.
None of this invalidates the LG CNS opportunity. It does explain why investors should keep sales pipeline, order intake and realized revenue in separate boxes — and why it would be premature to read the new letter of intent as a commercial breakthrough.
A prize in Japan, a different kind of signal
On the same day, D-Wave reported that its customer Shionogi took first place in the quality-of-life category of Japan's NEDO Quantum Computing Challenge. The ¥40 million prize is intended to fund further research into quantum-assisted drug discovery. The awarded work included a peer-reviewed study using D-Wave's annealing technology.
That is a genuine positive for the application of the technology, but it answers a different question than the allegations about bookings and deliveries. Research recognition and commercial execution are not the same thing, and a technology award does not by itself explain Wednesday's share price move.
November 10 is the next checkpoint
D-Wave will publish third-quarter 2026 results before the market opens on November 10, with a webcast scheduled for 8:00 a.m. Eastern Time. The report gives investors the next scheduled occasion to assess the business against published company figures.
What matters most is whether D-Wave can make the conversion of its opportunities into concrete orders and revenue legible. Binding contract terms and visible progress toward productive deployment would say more than any further list of possible use cases — and the company's communication should be held to that standard. The Korean partnership is a sensible approach with an open economic outcome; LG CNS can help pave the road to industrial applications, but the announcement alone does not earn a leap of faith.
Ad
D-Wave Quantum Stock: New Analysis - 29 October
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
